首頁 > 市場調查報告書 > 醫療設備

心血管設備電子醫療設備

市場調查報告書

商品編碼

1606543

全球醫院和實驗室設備市場 - 2024-2031

Global Hospital and Laboratory Equipment Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球醫院和實驗室設備市場達到419.2億美元，預計到2031年將達到777.3億美元，2024-2031年預測期間複合年成長率為8.0%。

醫院和實驗室設備是醫療保健和研究中用於診斷、治療和研究醫療狀況的各種工具和系統。它包括先進的影像設備，如 MRI 和 CT 掃描儀、病患監護系統、手術器械、實驗室分析儀和滅菌裝置。這些工具可確保準確的診斷、有效的治療和醫學研究的進步，同時滿足安全和品質標準。

市場動態：

驅動程式和限制

醫療基礎建設投資不斷增加

全球醫院和實驗室設備市場受到全球醫療保健基礎設施投資不斷增加的推動，特別是在新興經濟體。政府和私人組織正在投資現代化設施，以滿足對先進診斷和治療技術的需求。這一趨勢旨在加強患者護理、減少診斷錯誤並提高醫療程序效率。隨著醫療保健提供者努力提供更快、更準確的結果，自動化、機器人技術和人工智慧診斷工具等創新技術的採用也正在推動市場發展。

例如，2024 年 11 月，聯合化學和化肥部長 JP Nadda 啟動了一項 50 億盧比的計劃，以加強印度的醫療器材產業。該計劃旨在重點關注製造關鍵零件、技能開發、臨床研究支援、共同基礎設施發展和產業推廣。初始支出將持續三年，直至 2027 會計年度。該計劃由五個部分組成：醫療器材集群的公共設施、能力建設和技能發展、減少進口依賴的邊際投資計劃、臨床研究支援和醫療器材推廣計劃。 11億盧比已分配用於基礎設施開發，包括研發實驗室和測試設施。

此外，2024 年 9 月，Bertram Capital 投資了 MSE Supplies, LLC，這是一家位於圖森的先進材料、實驗室設備、實驗室用品和分析服務供應商。 MSE 透過 10,000 多種產品為 100 多個國家的科學家和工程師提供支援。這項投資是 Bertram 的第二個平台，也是對中低階市場企業的商業服務部門的首次投資。交易條款並未揭露。

嚴格的監管要求

由於 FDA、EMA 和 ISO 等機構制定的嚴格監管和合規要求，全球醫院和實驗室設備市場面臨重大挑戰。這些標準確保醫療和實驗室設備的安全性、有效性和品質。滿足這些標準需要進行廣泛的測試、臨床試驗和全面的文件記錄，從而導致新技術的批准時間過長，並可能出現延遲。由於缺乏財務和技術資源，製造商，特別是中小型企業 (SME)，很難駕馭這些監管框架。

Hospital and laboratory equipment is a diverse array of tools and systems used in healthcare and research to diagnose, treat, and study medical conditions. It includes advanced imaging devices like MRI and CT scanners, patient monitoring systems, surgical instruments, laboratory analyzers, and sterilization units. These tools ensure accurate diagnostics, effective treatments, and advancements in medical research, while meeting safety and quality standards.

Market Dynamics: Drivers & Restraints

Growing Investments in Healthcare Infrastructure

The global hospital and laboratory equipment market is driven by the increasing investment in healthcare infrastructure worldwide, particularly in emerging economies. Governments and private organizations are investing in modernizing facilities to meet the demand for advanced diagnostic and therapeutic technologies. This trend aims to enhance patient care, reduce diagnostic errors, and improve medical procedures efficiency. The adoption of innovative technologies like automation, robotics, and AI-powered diagnostic tools is also driving the market, as healthcare providers strive to deliver faster and more accurate results.

For instance, in November 2024, Union Chemicals and Fertilisers Minister JP Nadda has launched a Rs 500 crore scheme to strengthen India's medical devices industry. The scheme aims to focus on manufacturing key components and accessories, skill development, clinical studies support, common infrastructure development, and industry promotion. The initial outlay will last for three years, up to FY27. The scheme consists of five components: common facilities for medical device clusters, capacity building and skill development, a marginal investment scheme to reduce import dependence, clinical studies support, and a medical device promotion scheme. Rs 110 crore has been allocated for infrastructure development, including R&D labs and testing facilities.

Moreover, in September 2024, Bertram Capital has invested in MSE Supplies, LLC, a Tucson-based supplier of advanced materials, laboratory equipment, lab supplies, and analytical services. MSE supports scientists and engineers in over 100 countries with over 10,000 products. The investment is Bertram's second platform and first Business Services sector investment in lower middle market businesses. The terms of the transaction were not disclosed.

Stringent Regulatory Requirements

The global hospital and laboratory equipment market faces significant challenges due to stringent regulatory and compliance requirements set by bodies like the FDA, EMA, and ISO. These standards ensure safety, efficacy, and quality of medical and laboratory equipment. Meeting these standards requires extensive testing, clinical trials, and comprehensive documentation, leading to lengthy approval timelines and potential delays in new technologies. Manufacturers, particularly small and medium-sized enterprises (SMEs), struggle to navigate these regulatory frameworks due to lack of financial and technical resources.

Segment Analysis

The global hospital and laboratory equipment market is segmented based on product type, technology, end user and region.

Product type:

Hospital equipment segment is expected to dominate the hospital and laboratory equipment market share

The hospital equipment segment holds a major portion of the hospital and laboratory equipment market share and is expected to continue to hold a significant portion of the hospital and laboratory equipment market share during the forecast period.

Surgical instruments are essential tools for various medical procedures, including routine surgeries and complex interventions. They ensure precision, efficiency, and safety. The increasing prevalence of chronic diseases and the number of surgical procedures worldwide have driven the demand for high-quality, specialized instruments. Technological advancements, such as titanium and stainless steel integration, have improved the durability, sterility, and ergonomics of these instruments. Disposable surgical instruments have also addressed concerns about cross-contamination and infection control. The focus on improving surgical outcomes and reducing patient recovery times has further highlighted the importance of surgical instruments in the hospital and laboratory equipment market.

Laboratory Equipment:

Laboratory equipment segment is the fastest-growing segment in hospital and laboratory equipment market share

The laboratory equipment segment is the fastest-growing segment in the hospital and laboratory equipment market share and is expected to hold the market share over the forecast period.

Analytical instruments are crucial in the global hospital and laboratory equipment market, driving advancements in diagnostics, research, and quality control. They analyze biological samples, detect diseases, and monitor patient health. In hospitals, they guide treatment decisions through precise measurements of biochemical markers and blood gases. In laboratories, they facilitate research in genomics, proteomics, and drug development, fostering personalized medicine innovation. Technological innovations like automation and artificial intelligence have enhanced the speed, accuracy, and efficiency of analytical instruments, making them indispensable in modern healthcare and research settings. They also play a significant role in quality control in pharmaceutical manufacturing, ensuring regulatory compliance.

Geographical Analysis

North America is expected to hold a significant position in the hospital and laboratory equipment market share

North America holds a substantial position in the hospital and laboratory equipment market and is expected to hold most of the market share.

North America dominates the global hospital and laboratory equipment market due to advanced healthcare infrastructure, high healthcare expenditure, and strong technological adoption. Major medical device manufacturers, robust research funding, and high prevalence of chronic diseases contribute to its dominance. The demand for minimally invasive surgeries and precision diagnostics, coupled with favorable reimbursement policies, accelerates market growth. Government initiatives like the NIH and the growing focus on digital health technologies like AI-driven diagnostics and telemedicine further support the development and adoption of cutting-edge hospital and laboratory equipment.

For instance, in June 2024, Sky Medical Supplies has introduced a new line of affordable medical equipment, including manual and power wheelchairs, mobility scooters, hospital beds, oxygen concentrators, and lift chairs. The company's co-founder, Semaynesh Miftah, aims to provide reliable and affordable medical tools for a better quality of life. Sky Medical Supplies, founded in May 2021, also offers incontinence products, ADLs, and orthotics. The company's mission is to ensure everyone has access to necessary tools for a better quality of life.

Moreover, in September 2024, Thermo Fisher Scientific has launched Thermo Scientific Connect Edge, an enhanced hardware for the InstrumentConnect 24/7 laboratory equipment remote monitoring platform. Connect Edge is an Open Protocol Communication Unified Architecture server that allows users to send vital data to cloud or premise-based systems, including LIMS or BMS. It allows monitoring of 10 or more laboratory devices from a single gateway using Ethernet or Wi-Fi.

Asia-Pacific is growing at the fastest pace in the hospital and laboratory equipment market

Asia-Pacific holds the fastest pace in the hospital and laboratory equipment market and is expected to hold most of the market share due to economic development, healthcare infrastructure expansion, and investments. The growing population and prevalence of chronic and infectious diseases drive demand for advanced diagnostic and therapeutic equipment.

Moreover, Government initiatives in countries like China and India are promoting local manufacturing of medical devices, while advanced technologies like automated laboratory systems and precision medicine are gaining traction. The region's focus on medical tourism, particularly in cost-effective and high-quality countries, also drives demand for sophisticated hospital and laboratory equipment.

For instance, in January 2024, FUST Lab is a technology startup focusing on uniform nanoscale dispersion/emulsification technologies without surfactants, using ultrasonic technology and a spin-off from the Korea Research Institute of Standards and Science.

Competitive Landscape

The major global players in the hospital and laboratory equipment market include Medtronic, GE Healthcare, Philips Healthcare, Siemens Healthineers, Stryker Corporation, Hill-Rom Holdings, Inc., Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Inc, Roche Diagnostics among others.

Emerging Players

The emerging players in the hospital and laboratory equipment market include Biomerieux, Veeco Instruments, Molecular Devices and among others.

Key Developments

In August 2024, Metropolis Healthcare Limited has launched two advanced diagnostic laboratories in Telangana, Warangal and Nizamabad, as part of its strategic plan to improve diagnostic services in Tier 2 and Tier 3 cities. The facilities, covering 1,200 sq. ft., can process over 15,000 samples per month and offer a range of tests from basic pathology to advanced molecular diagnostics. By integrating state-of-the-art technology, Metropolis aims to strengthen local healthcare infrastructure and increase access to high-quality diagnostics for residents in these regions.
In October 2024, The Saudi Food and Drug Authority (SFDA) has launched an initiative to develop diagnostic laboratory equipment and advance 3D printing in hospitals. The initiative aims to foster innovation, research, and development while reducing costs for hospitals and medical laboratories. The equipment and reagents are provided for diagnostic and therapeutic use within hospitals and are not intended for commercial purposes. The initiative aligns with the SFDA's commitment to encouraging innovators, supporting national industries, and empowering investors regarding products under its oversight.
In October 2024, The Krishna Institute of Medical Sciences (KIMS) has signed a memorandum of understanding (MoU) with Wipro GE Healthcare to procure medical technology and services worth up to Rs 700 crore. The MoU covers new products, replacements, and sewices for 12 KIMS hospitals and 4 upcoming hospitals over the next three years. The MoU covers a full suite of medical technology products designed by Wipro GE Healthcare.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global hospital and laboratory equipment market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Investments in Healthcare Infrastructure
4.2. Restraints
- 4.2.1. Stringent Regulatory Requirements
4.3. Opportunity
- 4.3.1. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 6.1.2. Market Attractiveness Index, By Product type
6.2. Hospital Equipment *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Laboratory Equipment

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Automated Equipment*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Manual Equipment
7.4. Semi-Automated Systems

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Diagnostic Laboratories
8.4. Academic and Research Institutes
8.5. Specialty Clinics

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Medtronic Plc*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. GE Healthcare
11.3. Philips Healthcare
11.4. Siemens Healthineers
11.5. Stryker Corporation
11.6. Hill-Rom Holdings, Inc.
11.7. Thermo Fisher Scientific
11.8. Agilent Technologies
11.9. PerkinElmer, Inc
11.10. Roche Diagnostics (LIST NOT EXHAUSTIVE)